Lexaria Bioscience Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Lexaria Bioscience stock has a target of 7.00, which predicts an increase of 306.98% from the current stock price of 1.72.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$7.00	$7.00	$7.00	$7.00
Change	+306.98%	+306.98%	+306.98%	+306.98%

* Price targets were last updated on Jan 24, 2025.

Analyst Ratings

According to 1 stock analyst, the rating for Lexaria Bioscience is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	2	2	2	2	2	1
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	2	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Yi Chen HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $10 → $7	Strong Buy	Maintains	$10 → $7	+306.98%	Jan 24, 2025
Yi Chen HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $10	Strong Buy	Reiterates	$10	+481.40%	Dec 2, 2024
Yi Chen HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $10	Strong Buy	Reiterates	$10	+481.40%	Nov 25, 2024
Yi Chen HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $10	Strong Buy	Reiterates	$10	+481.40%	Jul 18, 2024
Yi Chen HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Initiates $10	Strong Buy	Initiates	$10	+481.40%	Jul 10, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

606.90K

from 464.28K

30.72%

from 464.28K

Revenue Next Year

800.19K

from 606.90K

31.85%

from 606.90K

EPS This Year

-0.60

from -0.47

EPS Next Year

-0.47

from -0.60

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Aug 31, 2020	Aug 31, 2021	Aug 31, 2022	Aug 31, 2023	Aug 31, 2024	Aug 31, 2025	Aug 31, 2026	Aug 31, 2027
Revenue	314.79K	722.74K	255.40K	226.21K	464.28K	606.90K	800.19K	2.51M
Revenue Growth	41.41%	129.59%	-64.66%	-11.43%	105.24%	30.72%	31.85%	213.68%
EPS	-1.42	-0.92	-1.24	-1.01	-0.47	-0.60	-0.47	-0.39
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	4	4	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	741,300	1.2M	3.7M
Avg	606,900	800,190	2.5M
Low	474,320	392,000	1.4M

Revenue Growth

Revenue Growth	2025	2026	2027
High	59.7%	102.2%	361.6%
Avg	30.7%	31.8%	213.7%
Low	2.2%	-35.4%	71.8%

EPS Forecast

EPS	2025	2026	2027
High	-0.60	-0.47	-0.40
Avg	-0.60	-0.47	-0.39
Low	-0.59	-0.46	-0.37

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.